StonvexLoading…
StonvexStonvexStonvexCore line items from PRME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $4.63M | $3.79M | $2.57M | $1.45M |
Operating Income | $-208.35M | $-159.74M | $-105.77M | $-52.39M |
Net Income | $-201.14M | $-155.06M | $-52.59M | $-51.89M |
EPS (Diluted) | $-1.35 | $-1.11 | $-0.81 | $-0.40 |
Total Assets | $342.73M | $385.01M | $279.01M | $328.16M |
Total Liabilities | $221.87M | $223.19M | $218.15M | $221.24M |
Cash & Equivalents | $63.03M | $71.40M | $53.80M | $91.88M |
Free Cash Flow OCF − CapEx | $-167.09M | $-129.55M | $-94.26M | $-51.28M |
Shares Outstanding | 180.51M | 180.31M | 134.49M | 131.16M |